Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

On Awe, Healthy Eating, Mental Health, Ethical Neurotech, and more

_____

Time to wrap-up anoth­er very active month with our Sharp­Brains e‑newsletter sum­ma­riz­ing excit­ing devel­op­ments in brain research, health­care and tech­nol­o­gy — plus a cou­ple fun brain teasers to spark curios­i­ty and inno­va­tion 🙂

New brain research:

New thinking about brain & mental health:

Emerging neurotech and digital brain health:

Finally, a couple fun brain teasers:

 

Have a excel­lent Hal­loween…

 

The Sharp­Brains Team

Novartis dissolves agreement to market Pear Therapeutics’ prescription digital therapeutics for substance/ opioid abuse

_______________

As San­doz returns mar­ket­ing rights for dig­i­tal ther­a­peu­tics to Pear, what does it mean for co-pro­mote arrange­ments? (MM&M):

San­doz, the gener­ics divi­sion of Novar­tis, is alter­ing com­mer­cial course, return­ing mar­ket­ing duties for two pre­scrip­tion dig­i­tal ther­a­peu­tics (DTx) back to Pear Ther­a­peu­tics. The move, which some had antic­i­pat­ed, comes 18 months after the two signed a co-pro­mo­tion deal.

Since the Sandoz/Pear pact was wide­ly seen as a lit­mus test of sorts for pharma’s role in help­ing dis­trib­ute this nascent tech­nol­o­gy, the com­mer­cial break-up rais­es ques­tions about the via­bil­i­ty of such part­ner­ships going for­ward. It also high­lights the par­ties’ some­times con­flict­ing pri­or­i­ties: Read the rest of this entry »

CVS Health: Cognitive behavioral therapy (CBT) apps may help you more than sleeping pills

__________

Sleep Ther­a­py for the Mass­es May Be Com­ing to You Soon (The New York Times):

CVS Health wants to help mil­lions of Amer­i­can work­ers improve their sleep. So for the first time, the big phar­ma­cy ben­e­fits man­ag­er is offer­ing a pure­ly dig­i­tal ther­a­py as a pos­si­ble employ­ee ben­e­fit.

The com­pa­ny is encour­ag­ing employ­ers to cov­er the costs for their work­ers to use Read the rest of this entry »

Lifestyle and neurotechnology over genetics

Dear col­league,

It’s remark­able how quick­ly things are chang­ing, final­ly, in brain health and men­tal health — see for exam­ple what’s new with Inter­ax­on, Akili, Neu­raMetrix, Apple, Calm, Halo Neu­ro­science, Mind­strong Health, Novar­tis, Pear Ther­a­peu­tics, and life­long neu­ro­ge­n­e­sis, all in the last 6 months!

Please enjoy the May edi­tion of Sharp­Brains eNewslet­ter below, and con­sid­er join­ing the Sharp­Brains Vir­tu­al Sum­mit this Decem­ber to dis­cuss the lat­est and help shape the next 🙂

New research:

New tools:

 

Have a great month of June,

 

The Sharp­Brains Team

Pear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health

___

Pear Ther­a­peu­tics rakes in $50M to devel­op addi­tion­al dig­i­tal ther­a­peu­tics (Mobi­Health­News):

Boston- and San Fran­cis­co-based Pear Ther­a­peu­tics, mak­er of a pre­scrip­tion dig­i­tal ther­a­peu­tic plat­form, announced today the clo­sure of $50 mil­lion in Series B fund­ing. The round was led by Sin­ga­pore-based invest­ment com­pa­ny Temasek, with par­tic­i­pa­tion from return­ing investors 5AM Ven­tures, Arbore­tum Ven­tures, and JAZZ Ven­ture Part­ners, as well as new part­ners Novar­tis, EDBI, and the Bridge Builder’s Col­lab­o­ra­tive Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.